BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 28409220)

  • 1. PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.
    Giovacchini G; Giovannini E; Leoncini R; Riondato M; Ciarmiello A
    Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1751-1776. PubMed ID: 28409220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
    Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis.
    Ouyang Q; Duan Z; Lei J; Jiao G
    Tumour Biol; 2016 Mar; 37(3):2999-3007. PubMed ID: 26415734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy.
    Giovacchini G; Picchio M; Garcia-Parra R; Briganti A; Abdollah F; Gianolli L; Schindler C; Montorsi F; Messa C; Fazio F
    J Nucl Med; 2014 Feb; 55(2):233-41. PubMed ID: 24408897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of choline PET in the era of prostate specific membrane antigen.
    Evangelista L; Cuppari L; Zattoni F; Mansi L; Bombardieri E
    Q J Nucl Med Mol Imaging; 2019 Mar; 63(1):19-28. PubMed ID: 29383928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of Prostate Cancer Using
    Hodolič M
    PET Clin; 2017 Apr; 12(2):173-184. PubMed ID: 28267451
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of Prostate Cancer with 11C-Choline PET/CT for Treatment Planning, Response Assessment, and Prognosis.
    Ceci F; Castellucci P; Mapelli P; Incerti E; Picchio M; Fanti S
    J Nucl Med; 2016 Oct; 57(Suppl 3):49S-54S. PubMed ID: 27694172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis.
    Umbehr MH; Müntener M; Hany T; Sulser T; Bachmann LM
    Eur Urol; 2013 Jul; 64(1):106-17. PubMed ID: 23628493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapidly changing landscape of PET/CT imaging in prostate cancer.
    Morigi JJ; Fanti S; Murphy D; Hofman MS
    Curr Opin Urol; 2016 Sep; 26(5):493-500. PubMed ID: 27467137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (11)C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series.
    Graziani T; Ceci F; Castellucci P; Polverari G; Lima GM; Lodi F; Morganti AG; Ardizzoni A; Schiavina R; Fanti S
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1971-9. PubMed ID: 27277279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restaging prostate cancer patients with biochemical failure with PET/CT and radiolabeled choline.
    Giovacchini G; Breeuwsma AJ
    Q J Nucl Med Mol Imaging; 2012 Aug; 56(4):354-66. PubMed ID: 23013665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer.
    Conde-Moreno AJ; Herrando-Parreño G; Muelas-Soria R; Ferrer-Rebolleda J; Broseta-Torres R; Cozar-Santiago MP; García-Piñón F; Ferrer-Albiach C
    Clin Transl Oncol; 2017 May; 19(5):553-561. PubMed ID: 27796820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer.
    Mapelli P; Incerti E; Ceci F; Castellucci P; Fanti S; Picchio M
    J Nucl Med; 2016 Oct; 57(Suppl 3):43S-48S. PubMed ID: 27694171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
    Schilling D; Schlemmer HP; Wagner PH; Böttcher P; Merseburger AS; Aschoff P; Bares R; Pfannenberg C; Ganswindt U; Corvin S; Stenzl A
    BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
    Beheshti M; Haim S; Zakavi R; Steinmair M; Waldenberger P; Kunit T; Nader M; Langsteger W; Loidl W
    J Nucl Med; 2013 Jun; 54(6):833-40. PubMed ID: 23559588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Prostate Cancer with 11C- and 18F-Choline PET/CT: Diagnosis and Initial Staging.
    Nitsch S; Hakenberg OW; Heuschkel M; Dräger D; Hildebrandt G; Krause BJ; Schwarzenböck SM
    J Nucl Med; 2016 Oct; 57(Suppl 3):38S-42S. PubMed ID: 27694169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of Prostate Cancer Using
    Castellucci P; Ceci F; Fanti S
    PET Clin; 2017 Apr; 12(2):137-143. PubMed ID: 28267448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.
    Rodado-Marina S; Coronado-Poggio M; García-Vicente AM; García-Garzón JR; Alonso-Farto JC; de la Jara AC; Maldonado-Suárez A; Rodríguez-Fernández A
    BJU Int; 2015 Jun; 115(6):874-83. PubMed ID: 25307619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer.
    Garcia JR; Romera N; Cozar M; Soler M; Moragas M; Escobar M
    Actas Urol Esp; 2015 May; 39(4):259-63. PubMed ID: 25454265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.